YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)

Parker Waichman Alonso LLP Headlines by Topic

Vytorin

Feds, State AGs Investigating Vytorin Marketing

Nov 4, 2008 | Parker Waichman Alonso LLP
Vytorin, Merck and Schering-Plough's controversial cholesterol medication, is the subject of two more state and federal investigations.  In a...

New Haven to Sue Merck and Schering-Plough

Oct 16, 2008 | Parker Waichman Alonso LLP
The city of New Haven, Connecticut, is reporting that over $400,000 in tax dollars were spent on Vytorin and Zetia for employees.  Now,...

Vytorin Sales Dip Means Layoffs at Schering-Plough

Sep 23, 2008 | Parker Waichman Alonso LLP
The Vytorin controversy is still hurting sales of the once-blockbuster cholesterol drug, with prescriptions down one-third this year.  To stem...

Vytorin Researcher Denies Cancer Link

Sep 19, 2008 | Parker Waichman Alonso LLP
A prominent statistician is continuing to insist that there is no link between Vytorin and cancer.  In a blunt letter to a Congressional...

Vytorin Confusion Leaves Patients Wondering

Sep 8, 2008 | Parker Waichman Alonso LLP
Many patients - and probably some doctors - are scratching their heads over Vytorin.  Though it has been on the market for four years, little is...

More Vytorin Questions from Congress

Sep 5, 2008 | Parker Waichman Alonso LLP
A Vytorin probe in Congress is expanding in scope.  The House Energy and Commerce Committee has been investigating the safety and effectiveness...

Vytorin Study Release Criticized

Sep 3, 2008 | Parker Waichman Alonso LLP
The behavior of Vytorin makers, Merck and Schering-Plough, in releasing the results of an important clinical trial that indicated the cholesterol...

Vytorin Cancer Controversy Far from Over

Aug 28, 2008 | Parker Waichman Alonso LLP
News earlier this summer that Vytorin had been tied to a higher risk of cancer by a newly published  study quickly faded from the...

Lawmakers Pressing for Answers on Vytorin Study

Aug 21, 2008 | Parker Waichman Alonso LLP
Two lawmakers want to know why the press release detailing a Vytorin study issued by drug makers Merck and Schering-Plough differed from information...

FDA Taking a Look at Vytorin - Cancer Link

Aug 21, 2008 | Parker Waichman Alonso LLP
Vytorin  is being investigated by federal regulators for a possible link to cancer.  The investigation stems from the publication last...

Page 2/6 [first] [prev] 1 2 3 4 5 6 [next] [last]

Vytorin
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

What condition was this medication prescribed to treat?


What Type of Incident Did You have (Heart Attack, Stroke, etc)

Incident Date

How Long Were You On Vytorin Before The Incident Occured

If other, please explain:

Did insurance cover your medication?

What was your total out of pocket expense?

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Social Security Disability | Contact
Statement of Clients' Rights | Site Map | Drug Injury Search | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome | Florida Personal Injury Law Firm

© 2002-2009 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News